Cargando…
Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a f...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579337/ https://www.ncbi.nlm.nih.gov/pubmed/36275631 http://dx.doi.org/10.3389/fmolb.2022.990861 |
_version_ | 1784812158999068672 |
---|---|
author | Sin, Yun Jin Ashley MacLeod, Rebecca Tanguay, Adam P. Wang, Andrew Braender-Carr, Olivia Vitelli, Teraesa M. Jay, Gregory D. Schmidt, Tannin A. Cowman, Mary K. |
author_facet | Sin, Yun Jin Ashley MacLeod, Rebecca Tanguay, Adam P. Wang, Andrew Braender-Carr, Olivia Vitelli, Teraesa M. Jay, Gregory D. Schmidt, Tannin A. Cowman, Mary K. |
author_sort | Sin, Yun Jin Ashley |
collection | PubMed |
description | The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a facile and general experimental approach to assay protein-mediated networking of HA in solution. Connections formed between two end-biotinylated 50 kDa HA (bHA) chains can be detected by signal arising from streptavidin-coated donor and acceptor beads being brought into close proximity when the bHA chains are bridged by proteins. We observed that incubation of bHA with the protein TSG-6 (tumor necrosis factor alpha stimulated gene/protein 6, TNFAIP/TSG-6) leads to dimerization or higher order multimerization of HA chains in solution. We compared two different heparin (HP) samples and two heparan sulfate (HS) samples for the ability to disrupt HA crosslinking by TSG-6. Both HP samples had approximately three sulfates per disaccharide, and both were effective in inhibiting HA crosslinking by TSG-6. HS with a relatively high degree of sulfation (1.75 per disaccharide) also inhibited TSG-6 mediated HA networking, while HS with a lower degree of sulfation (0.75 per disaccharide) was less effective. We further identified Proteoglycan 4 (PRG4, lubricin) as a TSG-6 ligand, and found it to inhibit TSG-6-mediated HA crosslinking. The effects of HP, HS, and PRG4 on HA crosslinking by TSG-6 were shown to be due to HP/HS/PRG4 inhibition of HA binding to the Link domain of TSG-6. Using the AlphaLISA platform, we also tested other HA-binding proteins for ability to create HA networks. The G1 domain of versican (VG1) effectively networked bHA in solution but required a higher concentration than TSG-6. Cartilage link protein (HAPLN1) and the HA binding protein segment of aggrecan (HABP, G1-IGD-G2) showed only low and variable magnitude HA networking effects. This study unambiguously demonstrates HA crosslinking in solution by TSG-6 and VG1 proteins, and establishes PRG4, HP and highly sulfated HS as modulators of TSG-6 mediated HA crosslinking. |
format | Online Article Text |
id | pubmed-9579337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95793372022-10-20 Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 Sin, Yun Jin Ashley MacLeod, Rebecca Tanguay, Adam P. Wang, Andrew Braender-Carr, Olivia Vitelli, Teraesa M. Jay, Gregory D. Schmidt, Tannin A. Cowman, Mary K. Front Mol Biosci Molecular Biosciences The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a facile and general experimental approach to assay protein-mediated networking of HA in solution. Connections formed between two end-biotinylated 50 kDa HA (bHA) chains can be detected by signal arising from streptavidin-coated donor and acceptor beads being brought into close proximity when the bHA chains are bridged by proteins. We observed that incubation of bHA with the protein TSG-6 (tumor necrosis factor alpha stimulated gene/protein 6, TNFAIP/TSG-6) leads to dimerization or higher order multimerization of HA chains in solution. We compared two different heparin (HP) samples and two heparan sulfate (HS) samples for the ability to disrupt HA crosslinking by TSG-6. Both HP samples had approximately three sulfates per disaccharide, and both were effective in inhibiting HA crosslinking by TSG-6. HS with a relatively high degree of sulfation (1.75 per disaccharide) also inhibited TSG-6 mediated HA networking, while HS with a lower degree of sulfation (0.75 per disaccharide) was less effective. We further identified Proteoglycan 4 (PRG4, lubricin) as a TSG-6 ligand, and found it to inhibit TSG-6-mediated HA crosslinking. The effects of HP, HS, and PRG4 on HA crosslinking by TSG-6 were shown to be due to HP/HS/PRG4 inhibition of HA binding to the Link domain of TSG-6. Using the AlphaLISA platform, we also tested other HA-binding proteins for ability to create HA networks. The G1 domain of versican (VG1) effectively networked bHA in solution but required a higher concentration than TSG-6. Cartilage link protein (HAPLN1) and the HA binding protein segment of aggrecan (HABP, G1-IGD-G2) showed only low and variable magnitude HA networking effects. This study unambiguously demonstrates HA crosslinking in solution by TSG-6 and VG1 proteins, and establishes PRG4, HP and highly sulfated HS as modulators of TSG-6 mediated HA crosslinking. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9579337/ /pubmed/36275631 http://dx.doi.org/10.3389/fmolb.2022.990861 Text en Copyright © 2022 Sin, MacLeod, Tanguay, Wang, Braender-Carr, Vitelli, Jay, Schmidt and Cowman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Sin, Yun Jin Ashley MacLeod, Rebecca Tanguay, Adam P. Wang, Andrew Braender-Carr, Olivia Vitelli, Teraesa M. Jay, Gregory D. Schmidt, Tannin A. Cowman, Mary K. Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title | Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title_full | Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title_fullStr | Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title_full_unstemmed | Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title_short | Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 |
title_sort | noncovalent hyaluronan crosslinking by tsg-6: modulation by heparin, heparan sulfate, and prg4 |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579337/ https://www.ncbi.nlm.nih.gov/pubmed/36275631 http://dx.doi.org/10.3389/fmolb.2022.990861 |
work_keys_str_mv | AT sinyunjinashley noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT macleodrebecca noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT tanguayadamp noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT wangandrew noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT braendercarrolivia noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT vitelliteraesam noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT jaygregoryd noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT schmidttannina noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 AT cowmanmaryk noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4 |